| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76cf08d0bce610252c36ffc8752ca808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2865c858d94b9c9aaa165286c83b1b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1203b9130a60c06c4f085efe9ae14a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-542 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542 |
| filingDate |
2006-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf000263e6d50e024577a167953227f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6870833521bbed5e86bc1ee68df71e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e83f6d1500b9ba4978ca1e451d68c4c4 |
| publicationDate |
2006-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006121963-A2 |
| titleOfInvention |
Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders |
| abstract |
Topical aqueous suspension compositions of sparingly soluble ophthalmic drugs are disclosed. The compositions comprise a combination of a poloxamer or meroxapol surfactant and a glycol tonicity-adjusting agent such as propylene glycol. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010528014-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013025696-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439590-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007127844-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510916-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9630909-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007127844-A2 |
| priorityDate |
2005-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |